Compare IRTC & HXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRTC | HXL |
|---|---|---|
| Founded | 2006 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.0B |
| IPO Year | 2016 | N/A |
| Metric | IRTC | HXL |
|---|---|---|
| Price | $170.86 | $72.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 8 |
| Target Price | ★ $203.93 | $72.88 |
| AVG Volume (30 Days) | 479.0K | ★ 1.3M |
| Earning Date | 10-30-2025 | 01-21-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.84 |
| Revenue | $702,573,000.00 | ★ $1,876,400,000.00 |
| Revenue This Year | $27.20 | $0.16 |
| Revenue Next Year | $16.89 | $10.49 |
| P/E Ratio | ★ N/A | $86.65 |
| Revenue Growth | ★ 25.45 | N/A |
| 52 Week Low | $84.17 | $45.28 |
| 52 Week High | $212.00 | $79.20 |
| Indicator | IRTC | HXL |
|---|---|---|
| Relative Strength Index (RSI) | 41.59 | 49.37 |
| Support Level | $167.07 | $71.98 |
| Resistance Level | $187.98 | $79.20 |
| Average True Range (ATR) | 6.17 | 1.85 |
| MACD | -1.31 | -0.55 |
| Stochastic Oscillator | 16.14 | 14.13 |
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Founded in 1948, Hexcel designs and manufactures a range of highly engineered composite fibers, fabrics, resins, and structures for use in the commercial aerospace, defense, and high-performance automotive markets. These are lighter than metal and perform under rigorous conditions in aircraft frames, wings, engines, and other components and subassemblies. The company's name derives from the six-sided honeycomb structures that lend many of its products their light weight and rigidity. Hexcel's biggest customers are Airbus (40% of 2024 sales) and Boeing (15% of 2024 sales; 25% before the pandemic) and their respective subcontractors.